These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

392 related articles for article (PubMed ID: 28097500)

  • 1. Update on Aspirin-Exacerbated Respiratory Disease.
    Woessner KM
    Curr Allergy Asthma Rep; 2017 Jan; 17(1):2. PubMed ID: 28097500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nasal Polyposis and Aspirin-Exacerbated Respiratory Disease.
    Luskin K; Thakrar H; White A
    Immunol Allergy Clin North Am; 2020 May; 40(2):329-343. PubMed ID: 32278455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aspirin exacerbated respiratory disease: Current topics and trends.
    Rodríguez-Jiménez JC; Moreno-Paz FJ; Terán LM; Guaní-Guerra E
    Respir Med; 2018 Feb; 135():62-75. PubMed ID: 29414455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin or other nonsteroidal inflammatory agent exacerbated asthma.
    Ledford DK; Wenzel SE; Lockey RF
    J Allergy Clin Immunol Pract; 2014; 2(6):653-7. PubMed ID: 25439353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Advances in aspirin-exacerbated respiratory disease (AERD)].
    Higashi N; Mitsui C; Taniguchi M
    Nihon Rinsho; 2016 Oct; 74(10):1683-1687. PubMed ID: 30551280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin-exacerbated respiratory disease (AERD): Current understanding of AERD.
    Taniguchi M; Mitsui C; Hayashi H; Ono E; Kajiwara K; Mita H; Watai K; Kamide Y; Fukutomi Y; Sekiya K; Higashi N
    Allergol Int; 2019 Jul; 68(3):289-295. PubMed ID: 31235242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aspirin-exacerbated respiratory disease and current treatment modalities.
    Sakalar EG; Muluk NB; Kar M; Cingi C
    Eur Arch Otorhinolaryngol; 2017 Mar; 274(3):1291-1300. PubMed ID: 27538737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspirin-exacerbated respiratory disease.
    Wangberg H; White AA
    Curr Opin Immunol; 2020 Oct; 66():9-13. PubMed ID: 32299015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term efficacy of aspirin desensitization in aspirin-exacerbated respiratory disease. Review of two clinical cases].
    Cambray-Gutiérrez JC; García-Ramírez UN; Del Rivero-Hernández LG; Lozano-Martínez SA; López-Pérez P; Chávez-García A
    Rev Alerg Mex; 2016; 63(2):207-12. PubMed ID: 27174764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Current complications and treatment of aspirin-exacerbated respiratory disease.
    Cook KA; Stevenson DD
    Expert Rev Respir Med; 2016 Dec; 10(12):1305-1316. PubMed ID: 27817219
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aspirin-Exacerbated Respiratory Disease and the Unified Airway: A Contemporary Review.
    Walters BK; Hagan JB; Divekar RD; Willson TJ; Stokken JK; Pinheiro-Neto CD; O'Brien EK; Choby G
    Otolaryngol Clin North Am; 2023 Feb; 56(1):107-124. PubMed ID: 36283868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Group 2 innate lymphoid cells are recruited to the nasal mucosa in patients with aspirin-exacerbated respiratory disease.
    Eastman JJ; Cavagnero KJ; Deconde AS; Kim AS; Karta MR; Broide DH; Zuraw BL; White AA; Christiansen SC; Doherty TA
    J Allergy Clin Immunol; 2017 Jul; 140(1):101-108.e3. PubMed ID: 28279492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Innate immune cell dysregulation drives inflammation and disease in aspirin-exacerbated respiratory disease.
    Eid R; Yan CH; Stevens W; Doherty TA; Borish L
    J Allergy Clin Immunol; 2021 Aug; 148(2):309-318. PubMed ID: 34364539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease.
    Haque R; White AA; Jackson DJ; Hopkins C
    J Allergy Clin Immunol; 2021 Aug; 148(2):283-291. PubMed ID: 34364538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid Mediators in Aspirin-Exacerbated Respiratory Disease.
    Parker AR; Ayars AG; Altman MC; Henderson WR
    Immunol Allergy Clin North Am; 2016 Nov; 36(4):749-763. PubMed ID: 27712768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term sinonasal outcomes of aspirin desensitization in aspirin exacerbated respiratory disease.
    Cho KS; Soudry E; Psaltis AJ; Nadeau KC; McGhee SA; Nayak JV; Hwang PH
    Otolaryngol Head Neck Surg; 2014 Oct; 151(4):575-81. PubMed ID: 25118195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aspirin-Exacerbated Respiratory Disease.
    Walgama ES; Hwang PH
    Otolaryngol Clin North Am; 2017 Feb; 50(1):83-94. PubMed ID: 27888917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New concepts for the pathogenesis and management of aspirin-exacerbated respiratory disease.
    Sehanobish E; Asad M; Jerschow E
    Curr Opin Allergy Clin Immunol; 2022 Feb; 22(1):42-48. PubMed ID: 34739410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Aspirin-Exacerbated Respiratory Disease: What Does the Future Hold?
    O'Brien EK; Jerschow E; Divekar RD
    Otolaryngol Clin North Am; 2024 Apr; 57(2):265-278. PubMed ID: 37833102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspirin-exacerbated respiratory disease: characteristics and management strategies.
    Simon RA; Dazy KM; Waldram JD
    Expert Rev Clin Immunol; 2015; 11(7):805-17. PubMed ID: 25936612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.